Inhibrx's Debt Round

Inhibrx raised a round of funding on April 09, 2015. Investors include Oxford Finance.

Inhibrx is a biologic immunotherapeutic company focused on the treatment of unmet medical needs. Inhibrx's proprietary platforms enable fit-for-function biotherapeutics that optimally interface with t…

Articles about Inhibrx's Debt Round: